Myelofibrosis and reduced intensity allogeneic hematopoietic stem cell transplantation (RISCT)

被引:1
|
作者
Popat, Uday R. [1 ]
Rondon, Gabriela [1 ]
Alousi, Amin M. [1 ]
Anderlini, Paolo [1 ]
Andersson, Borje S. [1 ]
De Lima, Marcos J. [1 ]
Giralt, Sergio A. [1 ]
Hosing, Chitra M. [1 ]
Kebriaei, Partow [1 ]
Jones, Roy [1 ]
Nieto, Yago [1 ]
Shpall, Elizabeth J. [1 ]
Verstovesek, Srdan [1 ]
Qazilbash, Muzaffar H. [1 ]
Champlin, Richard [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
关键词
D O I
10.1182/blood.V110.11.3062.3062
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3062
引用
收藏
页码:900A / 900A
页数:1
相关论文
共 50 条
  • [41] Reduced Intensity Stem Cell Transplantation for Accelerated Phase Myelofibrosis
    Gagelmann, Nico
    Badbaran, Anita
    Ditschkowski, Markus
    Panagiota, Victoria
    Cassinat, Bruno
    Heuser, Michael
    Thol, Felicitas
    Wolschke, Christine
    Salit, Rachel B.
    Robin, Marie
    Beelen, Dietrich W.
    Scott, Bart L.
    Kroeger, Nicolaus
    BLOOD, 2021, 138
  • [42] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML)
    U Popat
    H E Heslop
    A Durett
    R May
    R A Krance
    M K Brenner
    G Carrum
    Bone Marrow Transplantation, 2006, 37 : 547 - 552
  • [43] Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis
    Kroeger, N
    Zabelina, T
    Schieder, H
    Panse, J
    Ayuk, F
    Fehse, N
    Fehse, B
    Waschke, O
    Kvasnicka, HM
    Thiele, J
    Zander, A
    BLOOD, 2004, 104 (11) : 423A - 423A
  • [44] Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis
    Kim, Dong Hyun
    Seo, Jeongmin
    Shin, Dong-Yeop
    Koh, Youngil
    Hong, Junshik
    Kim, Inho
    Yoon, Sung-Soo
    Byun, Ja Min
    BLOOD RESEARCH, 2022, 57 (04) : 264 - 271
  • [45] Recent results of allogeneic stem cell transplantation for myelofibrosis using reduced intensity conditioning - the Swedish experience
    Lenhoff, S.
    Dreimane, A.
    Ejerblad, E.
    Isaksson, C.
    Ljungman, P.
    Brune, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S493 - S494
  • [46] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML)
    Popat, U
    Heslop, HE
    Durett, A
    May, R
    Krance, RA
    Brenner, MK
    Carrum, G
    BONE MARROW TRANSPLANTATION, 2006, 37 (06) : 547 - 552
  • [47] Allogeneic Stem Cell Transplantation in Myelofibrosis
    Jain, Tania
    Mesa, Ruben A.
    Palmer, Jeanne M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1429 - 1436
  • [48] Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis
    Jain, Tania
    Kunze, Katie L.
    Temkit, M'hamed
    Partain, Daniel K.
    Patnaik, Mrinal S.
    Slack, James L.
    Khera, Nandita
    Hogan, William J.
    Roy, Vivek
    Noel, Pierre
    Leis, Jose F.
    Sproat, Lisa Z.
    Fauble, Veena
    Mesa, Ruben A.
    Palmer, Jeanne
    BONE MARROW TRANSPLANTATION, 2019, 54 (02) : 204 - 211
  • [49] Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis
    Tania Jain
    Katie L. Kunze
    M’hamed Temkit
    Daniel K. Partain
    Mrinal S. Patnaik
    James L. Slack
    Nandita Khera
    William J. Hogan
    Vivek Roy
    Pierre Noel
    Jose F. Leis
    Lisa Z. Sproat
    Veena Fauble
    Ruben A. Mesa
    Jeanne Palmer
    Bone Marrow Transplantation, 2019, 54 : 204 - 211
  • [50] Allogeneic hematopoietic cell transplantation for patients with myelofibrosis
    Zang, Dae Young
    Deeg, H. Joachim
    CURRENT OPINION IN HEMATOLOGY, 2009, 16 (02) : 140 - 146